Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
Year: 1997
Type: article
Source: PubMed
Authors: R Krishna, L D Mayer
Institution: BC Cancer Agency
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1777880772
